The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients

Background Recently, a novel HOXB13 variant (X285K) was observed in men of African descent with prostate cancer (PCa) in Martinique. Little is known about this or other variants in HOXB13 which may play a role in PCa susceptibility in African-American (AA) men. Methods We sequenced HOXB13 in an AA p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of cancer 2022-03, Vol.126 (5), p.791-796
Hauptverfasser: Na, Rong, Wei, Jun, Sample, Chris J., Gielzak, Marta, Choi, Sodam, Cooney, Kathleen A., Rabizadeh, Daniel, Walsh, Patrick C., Zheng, Lilly S., Xu, Jianfeng, Isaacs, William B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Recently, a novel HOXB13 variant (X285K) was observed in men of African descent with prostate cancer (PCa) in Martinique. Little is known about this or other variants in HOXB13 which may play a role in PCa susceptibility in African-American (AA) men. Methods We sequenced HOXB13 in an AA population of 1048 men undergoing surgical treatment for PCa at Johns Hopkins Hospital. Results Seven non-synonymous germline variants were observed in the patient population. While six of these variants were seen only once, X285K was found in eight patients. In a case–case analysis, we find that carriers of this latter variant are at increased risk of clinically significant PCa (1.2% carrier rate in Gleason Score ≥7 PCa vs. 0% in Gleason Score
ISSN:0007-0920
1532-1827
DOI:10.1038/s41416-021-01622-4